ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,305, issued on July 28, was assigned to Reverb Therapeutics Inc. (Vancouver, Canada). "Cytokine-based therapies and methods" was invented b... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,306, issued on July 28, was assigned to UNIVERSITAT ZURICH (Zurich, Switzerland). "CD25-biased anti-IL-2 antibody" was invented by Onur Boy... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,307, issued on July 28, was assigned to GI INNOVATION INC. (Seoul, South Korea). "Pharmaceutical composition for treatment of cancer, compr... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,308, issued on July 28, was assigned to STEMCELL Technologies Canada Inc. (Vancouver, Canada). "Kits, compositions and methods for cell enr... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,309, issued on July 28, was assigned to QURE BIOTECHNOLOGY (SHANGHAI) Co. LTD. (Shanghai). "Anti-CLDN antibody and pharmaceutical compositi... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,310, issued on July 28, was assigned to Shanghaitech University (Shanghai). "ASIC1 channel antagonist antibody" was invented by Guang Yang ... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,311, issued on July 28, was assigned to William Robert Arathoon Living Trust Dated August 29, 2016 (Tiburon, Calif.). "Anti-MDR1 antibodies... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,312, issued on July 28, was assigned to BIOHENG THERAPEUTICS Ltd. (Grand Cayman, Cayman Islands). "CD7-targeting humanized antibody and use... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,313, issued on July 28, was assigned to AUTOLUS Ltd. (London). "Chimeric antigen receptor (CAR) comprising a CD19-binding domain" was inven... Read More
ALEXANDRIA, Va., July 28 -- United States Patent no. 12,692,314, issued on July 28, was assigned to IGI THERAPEUTICS SA (Neuchatel, Switzerland). "CD3/BCMA/CD38 trispecific antibodies" was invented b... Read More